These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 21439443

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Immunomodulatory treatments for multiple sclerosis: lessons from direct comparative studies].
    Ouallet JC.
    Rev Neurol (Paris); 2010 Jan; 166(1):21-31. PubMed ID: 19596382
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A practical approach to immunomodulatory therapy for multiple sclerosis.
    Burks JS.
    Phys Med Rehabil Clin N Am; 2005 May; 16(2):449-66, ix. PubMed ID: 15893681
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Multiple sclerosis disease-modifying therapies: adverse effect surveillance and management.
    Wingerchuk DM.
    Expert Rev Neurother; 2006 Mar; 6(3):333-46. PubMed ID: 16533138
    [Abstract] [Full Text] [Related]

  • 30. Long-term persistence with the immunomodulatory drugs for multiple sclerosis: a retrospective database study.
    Evans C, Tam J, Kingwell E, Oger J, University of British Columbia MS Clinic Neurologists, Tremlett H.
    Clin Ther; 2012 Feb; 34(2):341-50. PubMed ID: 22296946
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience.
    Pozzilli C, Prosperini L, Sbardella E, De Giglio L, Onesti E, Tomassini V.
    Neurol Sci; 2005 Dec; 26 Suppl 4():S174-8. PubMed ID: 16388353
    [Abstract] [Full Text] [Related]

  • 34. Natural history of multiple sclerosis: long-term prognostic factors.
    Renoux C.
    Neurol Clin; 2011 May; 29(2):293-308. PubMed ID: 21439442
    [Abstract] [Full Text] [Related]

  • 35. [Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis].
    Cazzato G, Antonello RM, Zorzon M, Torre P, Zivadinov R, Moretti R, Bragadin LM, De Masi R, Nasuelli D.
    Recenti Prog Med; 1999 Oct; 90(10):538-44. PubMed ID: 10592740
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Current treatment for multiple sclerosis].
    Papeix C, Lubetzki C, Lyon-Caen O.
    Presse Med; 2010 Mar; 39(3):381-8. PubMed ID: 20106633
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.